Key points are not available for this paper at this time.
Development of irAEs was associated with survival outcome of nivolumab treatment in patients with advanced or recurrent NSCLC. Further studies are needed to confirm our findings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Koji Haratani
Hidetoshi Hayashi
Yasutaka Chiba
JAMA Oncology
Kindai University
Osaka Minami Medical Center
Kindai University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Haratani et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d74e0cb1cb92dd1bb8a666 — DOI: https://doi.org/10.1001/jamaoncol.2017.2925